Advisors Asset Management, Inc. Johnson & Johnson Transaction History

Advisors Asset Management, Inc.

$4.99 Billion
Q2 2024

A detailed history of Advisors Asset Management, Inc. transactions in Johnson & Johnson stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 144,694 shares of JNJ stock, worth $23.4 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

144,694

Previous 122,500 18.12%

Holding current value

$23.4 Million

Previous $19.4 Million 9.13%

% of portfolio

0.42%

Previous 0.38%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$144.38 - $157.78 $3.2 Million - $3.5 Million	22,194 Added 18.12%	144,694 $21.1 Million
Q1 2024 May 14, 2024	BUY	$155.22 - $162.74 $3.46 Million - $3.63 Million	22,276 Added 22.23%	122,500 $19.4 Million
Q4 2023 Feb 14, 2024	BUY	$145.6 - $158.88 $2.46 Million - $2.69 Million	16,913 Added 20.3%	100,224 $15.7 Million
Q2 2023 Aug 14, 2023	BUY	$154.35 - $166.11 $1.85 Million - $1.99 Million	11,977 Added 16.79%	83,311 $13.8 Million
Q1 2023 May 12, 2023	SELL	$151.05 - $180.26 $1.73 Million - $2.06 Million	-11,451 Reduced 13.83%	71,334 $11.1 Million
Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $2.06 Million - $2.32 Million	-12,889 Reduced 13.47%	82,785 $14.6 Million
Q3 2022 Nov 08, 2022	SELL	$161.33 - $179.52 $1.6 Million - $1.78 Million	-9,932 Reduced 9.4%	95,674 $15.6 Million
Q2 2022 Aug 08, 2022	SELL	$168.19 - $186.01 $3.07 Million - $3.4 Million	-18,275 Reduced 14.75%	105,606 $18.7 Million
Q1 2022 May 17, 2022	SELL	$158.14 - $179.59 $2.42 Million - $2.75 Million	-15,317 Reduced 11.0%	123,881 $22 Million
Q4 2021 Feb 15, 2022	SELL	$155.93 - $173.01 $2.34 Million - $2.6 Million	-15,019 Reduced 9.74%	139,198 $23.8 Million
Q3 2021 Nov 12, 2021	SELL	$161.5 - $179.47 $7.48 Million - $8.31 Million	-46,309 Reduced 23.09%	154,217 $24.9 Million
Q2 2021 Jul 30, 2021	SELL	$159.48 - $171.07 $4.83 Million - $5.19 Million	-30,313 Reduced 13.13%	200,526 $33 Million
Q1 2021 May 07, 2021	SELL	$153.07 - $170.48 $2.28 Million - $2.54 Million	-14,904 Reduced 6.06%	230,839 $37.9 Million
Q4 2020 Feb 12, 2021	SELL	$137.11 - $157.38 $1.52 Million - $1.75 Million	-11,117 Reduced 4.33%	245,743 $38.7 Million
Q3 2020 Nov 16, 2020	BUY	$140.38 - $153.83 $1.53 Million - $1.68 Million	10,915 Added 4.44%	256,860 $38.2 Million
Q2 2020 Aug 12, 2020	BUY	$128.81 - $155.51 $690,421 - $833,533	5,360 Added 2.23%	245,945 $34.6 Million
Q1 2020 May 15, 2020	BUY	$111.14 - $153.99 $1.33 Million - $1.85 Million	11,998 Added 5.25%	240,585 $31.5 Million
Q4 2019 Feb 14, 2020	SELL	$127.5 - $146.44 $1.68 Million - $1.93 Million	-13,147 Reduced 5.44%	228,587 $34.5 Million
Q3 2019 Nov 14, 2019	SELL	$126.95 - $142.14 $220,893 - $247,323	-1,740 Reduced 0.71%	241,734 $31.3 Million
Q2 2019 Aug 14, 2019	SELL	$131.15 - $144.24 $1.37 Million - $1.51 Million	-10,480 Reduced 4.13%	243,474 $33.9 Million
Q1 2019 May 15, 2019	SELL	$125.72 - $139.79 $97,307 - $108,197	-774 Reduced 0.3%	253,954 $35.5 Million
Q4 2018 Jan 31, 2019	SELL	$122.84 - $147.84 $410,162 - $493,637	-3,339 Reduced 1.29%	254,728 $32.9 Million
Q3 2018 Nov 15, 2018	BUY	$121.58 - $142.88 $3.17 Million - $3.73 Million	26,092 Added 11.25%	258,067 $35.7 Million
Q2 2018 Aug 22, 2018	BUY	$119.4 - $131.76 $4.65 Million - $5.13 Million	38,948 Added 20.18%	231,975 $28.1 Million
Q2 2018 Aug 15, 2018	SELL	$119.4 - $131.76 $1.76 Million - $1.95 Million	-14,768 Reduced 7.11%	193,027 $28.1 Million
Q1 2018 May 15, 2018	BUY	$125.1 - $148.14 $1.92 Million - $2.28 Million	15,385 Added 8.0%	207,795 $27 Million
Q4 2017 Feb 13, 2018	BUY	$131.22 - $143.62 $1.33 Million - $1.46 Million	10,145 Added 5.57%	192,410 $26.9 Million
Q3 2017 Nov 07, 2017	BUY	$129.47 - $135.38 $23.6 Million - $24.7 Million	182,265	182,265 $23.7 Million

Others Institutions Holding JNJ

# of Institutions

4,162

Shares Held

1.69B

Call Options Held

12.5M

Put Options Held

10.3M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $424B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Johnson & Johnson Transaction History